These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12838298)

  • 1. Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
    Innes HE; Smith DB; O'Reilly SM; Clark PI; Kelly V; Marshall E
    Br J Cancer; 2003 Jul; 89(1):43-9. PubMed ID: 12838298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
    Coyle V; Forde C; Adams R; Agus A; Barnes R; Chau I; Clarke M; Doran A; Grayson M; McAuley D; McDowell C; Phair G; Plummer R; Storey D; Thomas A; Wilson R; McMullan R
    Health Technol Assess; 2024 Mar; 28(14):1-101. PubMed ID: 38512064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
    Niho S; Ohe Y; Goto K; Ohmatsu H; Matsumoto T; Kubota K; Kakinuma R; Nishiwaki Y
    Jpn J Clin Oncol; 2004 Feb; 34(2):69-73. PubMed ID: 15067098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
    J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
    Forde C; McMullan R; Clarke M; Wilson RH; Plummer R; Grayson M; McDowell C; Agus A; Doran A; McAuley DF; Thomas AL; Barnes RA; Adams R; Chau I; Coyle V
    Trials; 2020 May; 21(1):431. PubMed ID: 32460818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
    Kern WV; Marchetti O; Drgona L; Akan H; Aoun M; Akova M; de Bock R; Paesmans M; Viscoli C; Calandra T
    J Clin Oncol; 2013 Mar; 31(9):1149-56. PubMed ID: 23358983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
    Bash RO; Katz JA; Cash JV; Buchanan GR
    Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.
    Vedi A; Cohn R
    J Paediatr Child Health; 2013 Mar; 49(3):170-8. PubMed ID: 22136103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient treatment of neutropenic fever with oral antibiotics and granulocyte colony-stimulating factor.
    Papadimitris C; Dimopoulos MA; Kostis E; Papadimitriou C; Anagnostopoulos A; Alexopoulos G; Papamichael C; Gika D; Mitsibounas D; Stamatelopoulos S
    Oncology; 1999; 57(2):127-30. PubMed ID: 10461059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.
    Talcott JA; Yeap BY; Clark JA; Siegel RD; Loggers ET; Lu C; Godley PA
    J Clin Oncol; 2011 Oct; 29(30):3977-83. PubMed ID: 21931024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
    Sebban C; Dussart S; Fuhrmann C; Ghesquieres H; Rodrigues I; Geoffrois L; Devaux Y; Lancry L; Chvetzoff G; Bachelot T; Chelghoum M; Biron P
    Support Care Cancer; 2008 Sep; 16(9):1017-23. PubMed ID: 18197434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
    Paganini HR; Sarkis CM; De Martino MG; Zubizarreta PA; Casimir L; Fernandez C; Armada AA; Rodriguez-Brieshcke MT; Debbag R
    Cancer; 2000 Jun; 88(12):2848-52. PubMed ID: 10870071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
    Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics.
    Lau RC; Doyle JJ; Freedman MH; King SM; Richardson SE
    Pediatr Hematol Oncol; 1994; 11(4):417-21. PubMed ID: 7947014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule.
    Talcott JA; Whalen A; Clark J; Rieker PP; Finberg R
    J Clin Oncol; 1994 Jan; 12(1):107-14. PubMed ID: 8270967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
    J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.